Hemay005

· Ganzhou Hemay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Hemay005, covering 2018-06-19 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis [Phase 2]